Post-approval Observational Study of Elpida® in the First Line Therapy for HIV-1 Infected Patients With Background Standard ART

NCT03706950 · clinicaltrials.gov ↗
UNKNOWN
Status
2000
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Viriom